Suven Life Sciences Limited · (654.46) (2593.61) (946.84) (1295.65) (10640.08) (4004.57) 4 Net profit for the period After tax (after exceptional and / or extraordinary items) (407.74)

CS/NSE&BSE/UFR/2020-21 August 12, 2020

To The General Manager Department of Corporate Services BSE Limited 25th Floor, P. J. Towers, Dalai Street, Mumbai - 400001

Scrip Code: 530239

Dear Sir/Madam,

SUVEN Life Sciences

To The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kuria Complex Bandra (E), Mumbai - 400051

Scrip Symbol: SUVEN

Sub: Newspaper advertisement - Un-audited Financial Results of the Company for quarter ended 30th June, 2020

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Un-audited Financial Results of the Company for quarter ended 30th June, 2020. The advertisements are as appeared on 12th August, 2020 in Business Standard and Andhra Prabha (Telugu).

The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx

This is for your information and record.

Thanking you, Yours faithfully, For Suven Life Sciences Limited

Sint'enik Soni Company Secretary

Encl.: as above

Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7

Banjara Hills I Hyderabad — 500 034 I Telangana I India I CI N: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 3311/ 3315 Fax: 91 40 2354 1152 Email: [email protected] website: www.suven.com

Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7

Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 3311/ 3315 Fax: 91 40 2354 1152 Email: [email protected] website: www.suven.com

CS/NSE&BSE/UFR/2020-21 August 12, 2020

To The General Manager Department of Corporate Services BSE Limited 25th Floor, P. J. Towers, Dalal Street, Mumbai - 400001

To The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex Bandra (E), Mumbai – 400051

Scrip Code: 530239 Scrip Symbol: SUVEN

Dear Sir/Madam,

Sub: Newspaper advertisement – Un-audited Financial Results of the Company for quarter ended 30th June, 2020 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Un-audited Financial Results of the Company for quarter ended 30th June, 2020. The advertisements are as appeared on 12th August, 2020 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx This is for your information and record. Thanking you, Yours faithfully, For Suven Life Sciences Limited Shrenik Soni Company Secretary Encl.: as above

http://www.suven.com/newspaperads.aspx

21){5azdo 12 erIKE 2020 Eptsvaim8ls

c o .';.).35 E,7,-) -,,M37.5 e) a)E.35 53.7.96 re•gocQc.: 8-2-334..44m ''',,B ,TosA, tiC soeMi. dili 30.5. e36rg 7. oZ,Q4ned.e.:). 500 034. ason'o, soacer

mZ5 ! .3052411065131989t.V4M009713 CO: 91 40 2954 1142/3311/3315, 0•g5): 91 40 2354 1152.

s-33c.ud: [email protected], WIC: www.suven.com

es 30, 20208 5 6.3381)K1 5,130Mo Sat56.)

e& IScIfotO (3 o8 (5.06$5 tfoOctiv gmapc1.155 eig 4.11)§2Fte) c..3mdaAt.t:Ponlo cr. ° t at

te08 0645 5.6.0416

5. dittllavev

508,54 atatAdo

0»550 getlipo

&IAA ggrago

esNas agoomo

ave,Ist, eceepo

SIAM deseSo

go. 30/06/2020 31/03/2020 30/06/2019 30/06/2020 31/03/2020 30/06/2019

eadSceolso (WS:o aa6 &tam _.,

.546 dm= *SC Zug 68,06 &ISOM

asessicstse 5)08 Buds swabs 142.86 1441.47 159.49 142.86 1441.47 159.49

2 050 onso sway 0,6} teetSous.55/5.6 01080 / 6coeteuven o6 . ......+6S

(654.461 (2593.61) (94684) (1295.65) 110640.08) (400457)

3 0800p0me0811554,8181001a086Uli0800 5?516/8611,188 0019e600400418xamil

k554.461 (2593.61) (946.841 (1295.651 (10640.08) (4004„57)

4 080 eseoswevi gg.1.86.,04 mosacong

aft &ad%) / 6,8 80706ta oboo 0=14) (407.74) (1375.32)

454.43 (1048.93) (9421.791 12603301

5 agtio 88)0,inpod)o sy0ow41 Wool 01450 0,114,663gged) Woo:11)43M Atoaessolo (95.1,,,desewS)

8011 ceuaken

(415.12) (1404.86) 453.74 (1056.31) (9451.33) (2603.99)

6 oazet 0.4/. 0.0.0050 1272.82 127282 1272.82 1272.82 1272.82 1272.82 7 oat 046 (6 sg411tc510 0800 ax11.11)

add ,Sgx1 sp4.84 t4384,W4e,8g. Won. 3749453 13062.02

8 eye owee 0 cam* ,984,,11

Cog .0.32 -1.08 0,36 -0.82 -7.40 -2.05

E0,365 .0.32 .1.08 0.36 -0.82 .7.40 .2.05

(04soo,uoroo) (a.tec000gro) (0.40ft.."4.2.ta taVcoda.4011) 0,00o...126914 4S,4[..loaDSO

(751(09: E8 600000 Le (0 Soe,13o5 Olv 860 50986 83515,3x6,,) 864560,2015 ciSus, Ses,154,6 33 itoe,* ecode.91 easev,as depu n. 908.0 as., .43.0 ....... a..., Aeovolo. attusSIS eta 0044•0 eaves 83.0 *Sows * e4lot9 ou SueeSu 09.5 ,0618 07114,, Zek.Alev

(www.bseindia.com Waal» www nseind ia . corm wpm%) 9o80 cessie 3k045www.suven.com (vo61us4c468 tivku.

.13,5 gi PA 0.7.11315 8008) ZoStS 80

gsieo:tvecoess8 .045 & W.,

So: 11 e311.1, 2020 50088:00278028

•

Business Standard HYDERABAD [ WEDNESDAY, 12 AUGUST 2020 5

SUVEN LIFE SCIENCES LIMITED Regd Office: 8-2-334, SDE Serene Chambers, 6th Floor, Road No. 5, Avenue 7, Banjara Hills, 500 034, Telangana, India.

CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142 / 3311 / 3315 Fax: 91 40 2354 1152 Email: [email protected] Website: www.suven.com

EXTRACT OF UN-AUDITED STANDALONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2020

(2' in Lakhs

SI. No. Particulars

STANDALONE CONSOLIDATED

Quarter Ended

30/06/2020

Year Ended

31/03/2020

Quarter Ended

30/06/2019

Quarter Ended

30/06/2020

Year Ended

31/03/2020

Quarter Ended

30/06/2019

Un-audited Audited Un-audited Un-audited Audited Un-audited

1 Total income from operations 142.86 1441.47 159.49 142.86 1441.47 159.49

2 Net profit for the period (before tax, exceptional and / or extraordinary items)

(654.46) (2593.61) (946.84) (1295.65) (10640.08) (4004.57)

3 Net profit for the period before tax (after exceptional and / or extraordinary items)

(654.46) (2593.61) (946.84) (1295.65) (10640.08) (4004.57)

4 Net profit for the period After tax (after exceptional and / or extraordinary items)

(407.74) (1375.32) 454.43 (1048.93) (9421.79) (2603.30)

5 Total comprehensive income for the period [comprising profit for the period (after tax) and other comprehensive income (after tax)

(415,12) (1404.86) 453.74 (1056.31): (9451.33) (2603.99)

6 Equity share capital 1272.82 1272.82 1272.82 1272.82 1272.82 1272.82 7 Other Equity (Exduding Revaluation Reserve)

as shown in the audited balance sheet 37494.53 13062.02

8 Earnings Per Share (of Rs.1.00/- each)

1. Basic -0.32 -1.08 0.36 -0.82 -7.40 -2.05

2. Diluted -0.32 -1.08 0.36 -0.82 -7A0 -2.05

(not annualised) (not annualised) (not annualised) (not annualised) (not annualised) (not annualised)

Notes: The above is an extract of the detailed format of Quarterly Financial Results filed with the Stock Exchanges under Regulation 33 of the SEB (Listing and Other Disclosure Requirements) Regulations, 2015. The full format of the Quarterly Financial Results are available on the websites of the stock exchanges(s) and the listed entity. (www.bseindia.com and www.nseindia.com) and company's website www.suven.com.

For SUVEN LIFE SCIENCES LTD VENKAT JASTI Chairman & CEO DIN: 00278028

Place: Hyderabad Date : 11th, August 2020

Documents

Suven Life Sciences Limited · (654.46) (2593.61) (946.84) (1295.65) (10640.08) (4004.57) 4 Net profit for the period After tax (after exceptional and / or extraordinary items) (407.74)